Progesterone improves survival in hepatoma cachexia rat model
Abstract Background Medroxyprogesterone and megestrol acetate are synthetic progesterone derivatives. Progestagen is an approved drug for cancer cachexia in the USA and in some European countries. These agents have been described to increase appetite and to lead to weight gain. However, the effects...
Main Authors: | Tsuyoshi Suzuki, Nicole Ebner, Sandra Palus, Stephan vonHaehling, Jochen Springer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | JCSM Rapid Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/rco2.11 |
Similar Items
-
Body weight changes and incidence of cachexia after stroke
by: Nadja Scherbakov, et al.
Published: (2019-06-01) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2019-02-01) -
The Journal of Cachexia, Sarcopenia and Muscle in 2019
by: Stephan vonHaehling, et al.
Published: (2019-08-01) -
Hormonal mechanisms in body weight regulation and terapheutic implications
by: Bruno Geloneze Neto, et al.
Published: (2006-03-01) -
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis
by: Lucile Simon, et al.
Published: (2022-02-01)